21373834

Source:http://linkedlifedata.com/resource/pubmed/id/21373834

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004083, umls-concept:C0011860, umls-concept:C0021641, umls-concept:C0027361, umls-concept:C0086860, umls-concept:C0087111, umls-concept:C0205419, umls-concept:C0332307, umls-concept:C0686904, umls-concept:C1171304, umls-concept:C1412478, umls-concept:C2709063
pubmed:issue	6
pubmed:dateCreated	2011-5-6
pubmed:abstractText	An APOC3 promoter haplotype has been previously associated with type 1 diabetes. In this population-based study, we investigated whether APOC3 polymorphisms increase type 2 diabetes risk and need for insulin treatment in lean participants.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-10064091, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-10073946, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-10199885, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-10516792, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-10768089, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-10785873, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-11158011, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-11270684, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-12145780, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-12540728, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-12697301, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-15210953, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-15298351, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-15616039, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-16160865, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-16298371, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-16403005, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-16505251, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-1885781, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-1905629, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-1916053, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-19728115, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-2707516, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-67485, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-7106445, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-7705195, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-8039601, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-8099442, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-8200937, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-8227334, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-8675624, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-8971073, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-8977052, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-9178022, http://linkedlifedata.com/resource/pubmed/commentcorrection/21373834-9686693
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0006777
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein C-III, http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Insulin
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1432-0428
pubmed:author	pubmed-author:DehghanAA, pubmed-author:HofmanAA, pubmed-author:LieverseA GAG, pubmed-author:SijbrandsE J GEJ, pubmed-author:WittemanJ C MJC, pubmed-author:van DuijnC MCM, pubmed-author:van HerptT WTW, pubmed-author:van HoefBB
pubmed:issnType	Electronic
pubmed:volume	54
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1360-7
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:21373834-Aged, pubmed-meshheading:21373834-Aged, 80 and over, pubmed-meshheading:21373834-Alleles, pubmed-meshheading:21373834-Apolipoprotein C-III, pubmed-meshheading:21373834-Case-Control Studies, pubmed-meshheading:21373834-Cohort Studies, pubmed-meshheading:21373834-Diabetes Mellitus, Type 2, pubmed-meshheading:21373834-Female, pubmed-meshheading:21373834-Genetic Predisposition to Disease, pubmed-meshheading:21373834-Haplotypes, pubmed-meshheading:21373834-Humans, pubmed-meshheading:21373834-Hypoglycemic Agents, pubmed-meshheading:21373834-Insulin, pubmed-meshheading:21373834-Logistic Models, pubmed-meshheading:21373834-Male, pubmed-meshheading:21373834-Middle Aged, pubmed-meshheading:21373834-Netherlands, pubmed-meshheading:21373834-Polymorphism, Single Nucleotide, pubmed-meshheading:21373834-Prevalence, pubmed-meshheading:21373834-Promoter Regions, Genetic, pubmed-meshheading:21373834-Prospective Studies, pubmed-meshheading:21373834-Risk Factors, pubmed-meshheading:21373834-Thinness
pubmed:year	2011
pubmed:articleTitle	Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons.
pubmed:affiliation	Department of Internal Medicine, Erasmus Medical Center, PO Box 2040, 3000 CA Rotterdam, the Netherlands.

More...